Fresh2 Group Ltd (FRES)
$0.47461
+0.06
(+13.41%)▲
Insights on Fresh2 Group Ltd
Decreasing Revenue
Revenue is down for the last 2 quarters, 6.39M → 437.0K (in $), with an average decrease of 93.2% per quarter
Decreasing Net Profit
Netprofit is down for the last 2 quarters, -21.91M → -31.90M (in $), with an average decrease of 45.6% per quarter
Performance
- $0.41$0.48$0.47
12.74%
Downside
Day's Volatility :14.08%
Upside
1.53%
- $0.30$6.00$0.47
36.19%
Downside
52 Weeks Volatility :95.0%
Upside
92.17%
Returns
| Period | Fresh2 Group Ltd | Index (Russel 2000) |
|---|---|---|
3 Months | 10.12% | 0.0% |
6 Months | -50.05% | 0.0% |
1 Year | -90.84% | 0.0% |
3 Years | -90.84% | -19.4% |
Highlights
Market Capitalization | 10.3M |
Book Value | $10.3 |
Earnings Per Share (EPS) | -7.27 |
Profit Margin | 0.0% |
Operating Margin TTM | -698.85% |
Return On Assets TTM | -61.97% |
Return On Equity TTM | -216.23% |
Revenue TTM | 17.0M |
Revenue Per Share TTM | 3.83 |
Quarterly Revenue Growth YOY | -69.89999999999999% |
Gross Profit TTM | 0.0 |
EBITDA | -115.6M |
Diluted Eps TTM | -7.27 |
Quarterly Earnings Growth YOY | 0.0 |
EPS Estimate Current Year | 0.0 |
EPS Estimate Next Year | 0.0 |
EPS Estimate Current Quarter | 0.0 |
EPS Estimate Next Quarter | 0.0 |
Analyst Recommendation
- Current
- 1M Ago
- 3M Ago
Technicals Summary
Sell
Neutral
Buy
Fresh2 Group Ltd is currently in a favorable trading position ( BUY ) according to technical analysis indicators.
Peers
| Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
|---|---|---|---|---|---|
 Fresh2 Group Ltd | 28.87% | -50.05% | -90.84% | -90.84% | -90.84% |
 Moderna, Inc. | 31.05% | 68.31% | 5.28% | -15.88% | 488.05% |
 Regeneron Pharmaceuticals, Inc. | 9.53% | 22.54% | 29.41% | 92.5% | 224.65% |
 Novo Nordisk A/s | 7.48% | 27.32% | 54.67% | 229.52% | 458.15% |
 Vertex Pharmaceuticals Incorporated | 12.92% | 24.76% | 30.29% | 107.99% | 168.64% |
| Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
|---|---|---|---|---|---|---|---|---|
Fresh2 Group Ltd | NA | NA | NA | 0.0 | -2.16 | -0.62 | NA | 10.3 |
Moderna, Inc. | 24.73 | NA | 0.0 | -7.04 | -0.38 | -0.16 | NA | 33.47 |
Regeneron Pharmaceuticals, Inc. | 28.57 | 28.57 | 1.46 | 44.2 | 0.15 | 0.08 | NA | 250.15 |
Novo Nordisk A/s | 46.03 | 46.03 | 2.36 | 3.47 | 1.0 | 0.25 | 0.01 | 22.18 |
Vertex Pharmaceuticals Incorporated | 28.58 | 28.58 | 0.53 | 17.11 | 0.24 | 0.13 | NA | 71.8 |
| Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
|---|---|---|---|---|---|
Fresh2 Group Ltd | Buy | $10.3M | -90.84% | NA | 0.0% |
Moderna, Inc. | Buy | $50.8B | 488.05% | 24.73 | -115.82% |
Regeneron Pharmaceuticals, Inc. | Buy | $106.7B | 224.65% | 28.57 | 29.45% |
Novo Nordisk A/s | Buy | $593.5B | 458.15% | 46.03 | 36.55% |
Vertex Pharmaceuticals Incorporated | Buy | $113.7B | 168.64% | 28.58 | 39.46% |
Company Information
Organization | Fresh2 Group Ltd |
Employees | 75 |
CEO | Mr. Haohan Xu |
Industry | Miscellaneous |
Discover More
Daseke Inc
$0.47
+13.41%
A Spac I Acquisition Corp
$0.47
+13.41%
Gamida Cell Ltd
$0.47
+13.41%
Palladyne Ai Corp
$0.47
+13.41%
Keyarch Acquisition Corp
$0.47
+13.41%
Connexa Sports Technologies Inc
$0.47
+13.41%
Semantix Inc
$0.47
+13.41%
Arrowroot Acquisition Corp-a
$0.47
+13.41%
Anfield Capital Diversified Alternatives Etf
$0.47
+13.41%